India’s Ipca acquires U.S. drug contractor | January 29, 2018 Issue - Vol. 96 Issue 5 | Chemical & Engineering News
Volume 96 Issue 5 | p. 15 | Concentrates
Issue Date: January 29, 2018

India’s Ipca acquires U.S. drug contractor

Department: Business
Keywords: Process chemistry, acquisition, India

The Indian drug services firm Ipca Laboratories has purchased Pisgah Labs, a contract manufacturer of active pharmaceutical ingredients (APIs) in Pisgah Forest, N.C., for $9.7 million. The deal follows Ipca’s 2015 acquisition of Onyx Scientific, a U.K.-based specialist in custom synthesis, solid-state chemistry, and small-scale drug chemical production. Ipca says Pisgah will allow it to manufacture small-volume APIs in the U.S. as well.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment